Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
43,510,440
-
Total 13F shares
-
35,240,965
-
Share change
-
+35,121,321
-
Total reported value
-
$657,867,461
-
Put/Call ratio
-
95%
-
Price per share
-
$18.67
-
Number of holders
-
125
-
Value change
-
+$655,633,710
-
Number of buys
-
122
Institutional Holders of Kiniksa Pharmaceuticals International, plc - Common Stock (KNSA) as of Q2 2024
As of 30 Jun 2024,
Kiniksa Pharmaceuticals International, plc - Common Stock (KNSA) was held by
125 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,240,965 shares.
The largest 10 holders included
BlackRock Inc., Fairmount Funds Management LLC, HHLR ADVISORS, LTD., BAKER BROS. ADVISORS LP, Rubric Capital Management LP, BRAIDWELL LP, MORGAN STANLEY, STATE STREET CORP, Pictet Asset Management Holding SA, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
126
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.